Eluvixtamab (AMG-330)
Revision as of 19:50, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3